IDH1 and central nervous system cancer: Mutant IDH protein produces the oncometabolite D-2-hydroxyglutarate (2HG), which may establish the glioma-CpG island methylator phenotype (G-CIMP) (Noushmehr et al., 2010) by presumably extensive remodeling of the tumor methylome (Turcan et al., 2012).